10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis

The puerperium—the 6- to 12-week interval following childbirth—is characterized by rapid physiological involution, tissue remodeling, dynamic hormonal shifts, and altered hemodynamic parameters. During this vulnerable transitional phase, disruptions in host defenses or vascular flow predispose the postpartum individual to serious infectious, inflammatory, and thromboembolic pathologies. The certified nurse-midwife must maintain high diagnostic vigilance, systematically differentiate benign puerperal variations from fulminant systemic disease, and execute evidence-based medical and collaborative interventions.

---

Puerperal Endometritis: Diagnostic Criteria & Bacteriology

Puerperal endometritis (also termed endomyometritis or endoparametritis) is an infection of the decidua, underlying myometrium, and surrounding parametrial tissues. It represents the most common cause of postpartum fever.

Clinical Definition

The standard clinical diagnostic criteria for puerperal morbidity and endometritis are:

• Maternal oral temperature ≥38.0°C (100.4°F) occurring on any two of the first 10 postpartum days, excluding the first 24 hours following birth.
• The First 24-Hour Rule: Transient, low-grade temperature elevations (<38.0°C / 100.4°F) during the first 24 hours postpartum are exceptionally common and typically reflect physiological dehydration, tissue trauma, and inflammatory cytokine release from labor muscular exertion. However, high fever (≥38.5°C / 101.3°F) or fever accompanied by maternal tachycardia, chills, or hypotension within the first 24 hours cannot be dismissed as dehydration and mandates immediate evaluation.

Epidemiologic Risk Factors

1. Cesarean Delivery: The single most powerful predisposing risk factor for postpartum endometritis. Compared to spontaneous vaginal delivery (incidence 1% to 3%), cesarean delivery increases the risk 5- to 20-fold (incidence 10% to 25% without antibiotic prophylaxis). Foreign suture material, myometrial incision necrosis, tissue hematomas, and uterine exteriorization contribute to this dramatic elevation.
2. Prolonged Rupture of Membranes (PROM): Rupture of membranes >18 to 24 hours allows progressive upward migration of cervicovaginal microorganisms.
3. Prolonged Labor & Monitoring: Prolonged second stage of labor; frequent digital pelvic examinations (≥5 exams); placement of internal monitoring devices (intrauterine pressure catheter [IUPC], fetal scalp electrode [FSE]).
4. Intra-amniotic Infection (Chorioamnionitis): Antepartum or intrapartum infection directly establishes postpartum endometritis.
5. Obstetric Interventions: Manual removal of the placenta, operative vaginal delivery (forceps or vacuum), and untreated Group B Streptococcus (GBS) colonization.

Polymicrobial Bacteriology

Puerperal endometritis is predominantly a polymicrobial infection arising from ascending endogenous cervicovaginal flora. On average, two to three distinct bacterial pathogens are isolated from the endometrial cavity, encompassing both aerobic and anaerobic species:

• Aerobic Gram-Positive Cocci: Group B Streptococcus (Streptococcus agalactiae), Enterococcus faecalis, and Staphylococcus aureus.
• Aerobic Gram-Negative Bacilli: Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
• Anaerobic Organisms: Peptostreptococcus species, Bacteroides fragilis, Prevotella bivia, and Fusobacterium species.
• Special Clinical Pathogen — Group A Streptococcus (GAS, Streptococcus pyogenes): Highly virulent exogenous or endogenous pathogen capable of causing rapidly lethal toxic shock-like puerperal sepsis. GAS endometritis often manifests in the first 24 hours with high spiking fevers, profound tachycardia, minimal or serosanguinous odorless lochia, rapid tissue destruction, and septic shock.

Clinical Presentation

• Temperature elevation (frequently 38.3°C to 40.0°C / 101°F to 104°F) with associated rigors and diaphoresis.
• Exquisite uterine fundal tenderness: The hallmark physical exam finding; gentle bimanual examination or abdominal fundal palpation elicits severe tenderness.
• Uterine Subinvolution: The uterine fundus is boggy, soft, and larger/higher in the abdomen than expected for the corresponding postpartum day.
• Lochia Characteristics: Foul-smelling, purulent, or dark brown lochia is common with anaerobic infections. Clinical Pearl: Absence of malodorous lochia does NOT exclude endometritis (infections caused by GBS or GAS typically produce thin, odorless, scanty lochia).
• Leukocytosis: White blood cell (WBC) count >15,000 to 25,000/mcL with a notable "left shift" (>10% immature band forms). Note: A physiologic leukocytosis up to 15,000–20,000/mcL is normal in early puerperium; the presence of bandemia, toxic granulation, and maternal clinical toxicity distinguishes true infection.

---

Stepwise Antimicrobial Management of Endometritis

Puerperal endometritis following cesarean delivery or severe post-vaginal birth requires prompt broad-spectrum intravenous antimicrobial therapy.

Endometritis Treatment Cascade
├── First-Line Gold Standard IV Regimen
│   ├── Clindamycin 900 mg IV q8h (potent anaerobic + Gram-positive coverage)
│   └── Gentamicin 5 mg/kg IV q24h once daily (Gram-negative enteric bacilli coverage)
│       └── Continue until afebrile & asymptomatic for 24 - 48 hours (90-95% cure)
└── If Fever Persists >48 - 72 Hours (Treatment Failure)
    ├── 1. Add Ampicillin 2 g IV q6h (covers Enterococcus faecalis)
    ├── 2. Perform Pelvic Imaging (CT or MRI with contrast)
    │   ├── Rule out infected pelvic hematoma / abscess
    │   └── Rule out retained infected products of conception
    └── 3. Evaluate for Septic Pelvic Thrombophlebitis (SPT) -> Heparin Challenge

The Gold Standard Regimen

• Clindamycin 900 mg IV every 8 hours PLUS Gentamicin 5 mg/kg IV once every 24 hours (or 1.5 mg/kg IV every 8 hours).
  • Mechanism & Rationale: Clindamycin provides exceptional coverage against anaerobic organisms (including Bacteroides fragilis) and gram-positive cocci. Gentamicin provides potent bactericidal coverage against gram-negative aerobes like E. coli. Once-daily gentamicin dosing achieves high peak concentrations with reduced nephrotoxicity and ototoxicity.
  • Clinical Success: Resolves 90% to 95% of cases within 48 to 72 hours.
• Discharge Criteria & Oral Antibiotics: Intravenous antibiotics are maintained until the patient is completely afebrile (<37.8°C / 100.0°F), non-tender, and asymptomatic for 24 to 48 hours.
• AMCB Board Rule: Oral outpatient antibiotics following successful parenteral therapy are NOT necessary or recommended. Multiple randomized trials show that continuing oral antibiotics after clinical defervescence provides no therapeutic benefit and increases antibiotic resistance and gastrointestinal side effects.

Management of Persistent Fever (>48 to 72 Hours)

If the patient remains febrile after 48 to 72 hours of adequate clindamycin and gentamicin therapy:

1. Add Ampicillin: Administer Ampicillin 2 g IV every 6 hours (or substitute ampicillin-sulbactam). Ampicillin specifically covers Enterococcus faecalis, an intrinsically resistant pathogen to clindamycin and aminoglycosides.
2. Diagnostic Imaging: Order a contrast-enhanced pelvic CT or MRI to evaluate for retained infected placental tissue, uterine incisional dehiscence, pelvic phlegmon, or deep pelvic abscess.
3. Investigate Septic Pelvic Thrombophlebitis: If imaging is negative and fevers continue, evaluate for pelvic vein thrombosis.

---

Septic Pelvic Thrombophlebitis (SPT)

Septic pelvic thrombophlebitis is a serious complication characterized by bacterial infection and secondary thrombosis of the deep pelvic venous plexuses or ovarian veins.

• Pathophysiology: Bacteria ascend through pelvic lymphatics and uterine veins, injuring the vascular endothelium and inciting thrombus formation in slow-moving pelvic venous channels. The right ovarian vein is involved in over 90% of cases due to its longer anatomic trajectory and physiologic uterine dextrorotation.
• Clinical Presentation: Characterized by persistent, erratic "picket-fence" fever spikes (temperatures fluctuating from 38.0°C to 40.5°C with intervening normal periods) accompanied by resting tachycardia, unresponsive to 48 to 72 hours of broad-spectrum triple-antibiotic therapy.
  • Importantly, patients often appear relatively comfortable between fever spikes, with minimal abdominal tenderness and no peritoneal signs.
• Diagnostic Confirmation:
  • Imaging: Contrast-enhanced pelvic CT or MRI demonstrating a non-enhancing intraluminal filling defect within an enlarged ovarian or pelvic vein.
  • The Heparin Challenge: When imaging is equivocal, a therapeutic challenge of intravenous unfractionated heparin or low-molecular-weight heparin is initiated. Dramatic clinical defervescence within 24 to 48 hours of anticoagulation strongly supports the diagnosis of SPT.
• Management: Full therapeutic anticoagulation maintained in conjunction with continued broad-spectrum IV antibiotics until fever-free for 48 to 72 hours.

---